Search Results - "Kevin, Richard"
-
1
The Genotypic View of Social Interactions in Microbial Communities
Published in Annual review of genetics (01-01-2013)“…Dense and diverse microbial communities are found in many environments. Disentangling the social interactions between strains and species is central to…”
Get full text
Journal Article -
2
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Published in Psychopharmacology (01-09-2019)“…Background The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a…”
Get full text
Journal Article -
3
Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A‑CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
Published in ACS chemical neuroscience (16-12-2020)“…Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive substances (NPS) with structurally diverse compounds emerging each…”
Get full text
Journal Article -
4
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
Published in Journal of psychopharmacology (Oxford) (01-12-2022)“…Background: Cannabidiol (CBD), a major cannabinoid of Cannabis sativa, is widely consumed in prescription and non-prescription products. While CBD is generally…”
Get full text
Journal Article -
5
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Published in ACS chemical neuroscience (16-09-2015)“…Synthetic cannabinoid (SC) designer drugs based on indole and indazole scaffolds and featuring l-valinamide or l-tert-leucinamide side chains are encountered…”
Get full text
Journal Article -
6
Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People
Published in Journal of clinical psychopharmacology (01-09-2021)“…Cannabidiol (CBD), a major nonintoxicating constituent of cannabis, exhibits anxiolytic properties in preclinical and human studies and is of interest as a…”
Get full text
Journal Article -
7
Defensive aggregation (huddling) in Rattus norvegicus toward predator odor: individual differences, social buffering effects and neural correlates
Published in PloS one (29-07-2013)“…Aggregation is a defensive strategy employed by many prey species in response to predatory threat. Our group has characterized defensive aggregation (huddling)…”
Get full text
Journal Article -
8
Laboratory Comparison of Low-Cost Particulate Matter Sensors to Measure Transient Events of Pollution
Published in Sensors (Basel, Switzerland) (15-04-2020)“…Airborne particulate matter (PM) exposure has been identified as a key environmental risk factor, associated especially with diseases of the respiratory and…”
Get full text
Journal Article -
9
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Published in Scientific reports (23-05-2024)“…Hand osteoarthritis (OA) is an irreversible degenerative condition causing chronic pain and impaired functionality. Existing treatment options are often…”
Get full text
Journal Article -
10
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA
Published in The Journal of pharmacology and experimental therapeutics (01-05-2018)“…Synthetic cannabinoids are a class of novel psychoactive substances that exhibit high affinity at the cannabinoid type-1 (CB ) receptor and produce effects…”
Get more information
Journal Article -
11
Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
Published in Behavioural pharmacology (01-09-2020)“…The major phytocannabinoid cannabidiol (CBD) has anxiolytic properties and lacks tetrahydrocannabinol-like psychoactivity. Cannabidiolic acid (CBDA) is the…”
Get full text
Journal Article -
12
Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis
Published in Neuroscience and biobehavioral reviews (01-03-2022)“…•THC-related biomarkers were associated with impairment in occasional cannabis users.•However, most of these ‘biomarker–performance’ relationships were ‘weak’…”
Get full text
Journal Article -
13
Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Published in ACS chemical neuroscience (19-08-2015)“…Synthetic cannabinoid (SC) designer drugs featuring bioisosteric fluorine substitution are identified by forensic chemists and toxicologists with increasing…”
Get full text
Journal Article -
14
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
Published in Frontiers in psychiatry (15-12-2022)“…Synthetic cannabinoid receptor agonists (SCRAs) are a diverse class of new psychoactive substances that have been associated with multiple instances and types…”
Get full text
Journal Article -
15
Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
Published in Addiction biology (01-03-2022)“…Some evidence suggests that males and females may differ in their responses to acute cannabis effects, including subjective drug effects and behavioural…”
Get full text
Journal Article -
16
Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues
Published in ACS chemical neuroscience (18-10-2017)“…Synthetic cannabinoids (SC) are the largest class of new psychoactive substances (NPS), and are increasingly associated with serious adverse effects. The…”
Get full text
Journal Article -
17
A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa
Published in Psychoneuroendocrinology (01-06-2024)“…Anorexia nervosa (AN) is an eating disorder (ED) with high mortality rates and limited response to existing treatments, prompting the need to identify…”
Get full text
Journal Article -
18
Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors
Published in The Journal of pharmacology and experimental therapeutics (01-03-2019)“…Synthetic cannabinoids (SCs) are novel psychoactive substances that are easily acquired, widely abused as a substitute for cannabis, and associated with…”
Get more information
Journal Article -
19
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences
Published in The Journal of pharmacology and experimental therapeutics (01-04-2017)“…Synthetic cannabinoids are manufactured clandestinely with little quality control and are distributed as herbal "spice" for smoking or as bulk compound for…”
Get more information
Journal Article -
20
MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
Published in Frontiers in physiology (04-04-2023)“…T-type Ca channels (Ca 3) represent emerging therapeutic targets for a range of neurological disorders, including epilepsy and pain. To aid the development and…”
Get full text
Journal Article